These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 17036955)
21. [Diabetics' life is about one third shorter. So you improve the prognosis of these high-risk patients]. Stiefelhagen P MMW Fortschr Med; 2003 Apr; 145(15):18, 20. PubMed ID: 15104261 [No Abstract] [Full Text] [Related]
22. [Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland?]. Nanchen D; Chiolero A; Marques-Vidal PM; Cornuz J; Waeber G; Vollenweider P; Rodondi N Rev Med Suisse; 2010 Mar; 6(239):488-90, 492-3. PubMed ID: 20373694 [TBL] [Abstract][Full Text] [Related]
23. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials. Saha SA; Molnar J; Arora RR J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946 [TBL] [Abstract][Full Text] [Related]
24. [The superpill--solution for all vascular diseases? Hardly! Furthermore, it undermines health services and science]. Werkö L Lakartidningen; 2003 Sep; 100(39):3022-3. PubMed ID: 14560667 [No Abstract] [Full Text] [Related]
26. Statins and stroke prevention. Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685 [TBL] [Abstract][Full Text] [Related]
27. [Therapy of dyslipidemia in post-infarction: state of the art]. Borgia MC; Nardi M; Da Ros S; Castellano V Clin Ter; 2007; 158(6):523-32. PubMed ID: 18265719 [TBL] [Abstract][Full Text] [Related]
29. [New goals in secondary prevention. "It does not make sense to stop at 100 mg/dl LDL"]. Klör HU MMW Fortschr Med; 2005 Mar; 147(12):5. PubMed ID: 15832779 [No Abstract] [Full Text] [Related]
30. [Introduction. Residual atherothrombotic risk. Does it exist?]. Tavazzi L; Ambrosio G G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):3S-5S. PubMed ID: 18773745 [No Abstract] [Full Text] [Related]
31. Treatment of high-risk older persons with lipid-lowering drug therapy. Aronow WS Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628 [TBL] [Abstract][Full Text] [Related]
33. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548 [TBL] [Abstract][Full Text] [Related]
34. [C-reactive protein: cardiovascular issues of an acute-phase protein]. Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194 [TBL] [Abstract][Full Text] [Related]
35. Low-density lipoprotein reduction and magnitude of cardiovascular risk reduction. Rahilly-Tierney CR; Lawler EV; Scranton RE; Michael Gaziano J Prev Cardiol; 2009; 12(2):80-7. PubMed ID: 19476581 [TBL] [Abstract][Full Text] [Related]
36. Evidence based hypolipidaemic drug treatment. Mant A Aust Fam Physician; 2000 Jan; 29(1):58-9. PubMed ID: 10721547 [No Abstract] [Full Text] [Related]
38. [European Hypertension Congress initiative: implement modern risk management without further delay!]. Aumiller J MMW Fortschr Med; 2005 Sep; 147(38):39, 41-2. PubMed ID: 16218227 [No Abstract] [Full Text] [Related]
39. Impact of recent trial results on cardiovascular risk management (Hatter Institute Cardiac Horizons series). Cardiovasc J Afr; 2008; 19(6):328-31. PubMed ID: 19104733 [No Abstract] [Full Text] [Related]
40. [Emergency administration of statins in hospital. Measures concerning life style of coronary patients are still not to be forgotten]. Olsson AG Lakartidningen; 2001 May; 98(22):2704-6. PubMed ID: 11430227 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]